IDXG · CIK 0001054102 · FY2025 live · 2025-12-31
INTERPACE BIOSCIENCES, INC.
View as
Model
Classic Z
FY2025
−5.84
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
29.18
0–100 · Classic Z tape · not a PD
Book standing
15
Year change
—
Market PD
—
O-score
67
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
−5.84
Z″ −16.52
Score −5.84 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.141.2 × = 0.17X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−6.231.4 × = −8.72X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
0.123.3 × = 0.40X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
1.950.6 × = 1.17X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
1.141 × = 1.14
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
INTERPACE BIOSCIENCES, INC. is on classic Z at −5.84 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 26th percentile in Healthcare.
- LCTXDistressLineage Cell Therapeutics, Inc.−5.86
- NPCEDistressNeuroPace Inc−5.89
- SCYXDistressSCYNEXIS INC−5.91
- CABADistressCabaletta Bio, Inc.−5.91
- NVCTDistressNuvectis Pharma, Inc.−5.74
- MGTXDistressMeiraGTx Holdings plc−5.94
- SRRKDistressScholar Rock Holding Corp−5.74
- MISTDistressMilestone Pharmaceuticals Inc.−5.73
KPI widgets
Current assets
$10M
Total assets
$34M
Current liabilities
$5M
Total liabilities
$11M
Working capital
$5M
Retained earnings
−$211M
EBIT
$4M
Total sales
$39M
Book equity
$22M
Accession 0001493152-26-013646. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.